Bionano Genomics, Inc.
NASDAQ:BNGO
5 (USD) • At close February 4, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Bionano Genomics, Inc. |
Symbool | BNGO |
Munteenheid | USD |
Prijs | 5 |
Beurswaarde | 11,652,000 |
Dividendpercentage | 0% |
52-weken bereik | 4.75 - 81 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Robert Erik Holmlin M.B.A., Ph.D. |
Website | https://www.bionanogenomics.com |
An error occurred while fetching data.
Over Bionano Genomics, Inc.
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)